000			01670 a2200445 4500
005			20250516051219.0
264		0	_c20120127
008			201201s 0 0 eng d
022			_a1095-8584
024	7		_a10.1016/j.yjmcc.2011.07.020 _2doi
040			_aNLM _beng _cNLM
100	1		_aBruedigam, Claudia
245	0	0	_aOpposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells. _h[electronic resource]
260			_bJournal of molecular and cellular cardiology _cNov 2011
300			_a862-71 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAtherosclerosis _xdrug therapy
650	0	4	_aCaspases _xgenetics
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aDiabetes Mellitus _xdrug therapy
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadverse effects
650	0	4	_aMuscle, Smooth, Vascular _xcytology
650	0	4	_aMyocytes, Smooth Muscle _xcytology
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aResveratrol
650	0	4	_aRosiglitazone
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aStilbenes _xpharmacology
650	0	4	_aThiazolidinediones _xadverse effects
650	0	4	_aUp-Regulation
700	1		_aEijken, Marco
700	1		_aKoedam, Marijke
700	1		_aChiba, Hideki
700	1		_avan Leeuwen, Johannes P T M
773	0		_tJournal of molecular and cellular cardiology _gvol. 51 _gno. 5 _gp. 862-71
856	4	0	_uhttps://doi.org/10.1016/j.yjmcc.2011.07.020 _zAvailable from publisher's website
999			_c21061240 _d21061240